Groupe Hospitalier Pellegrin
Groupe Hospitalier Pellegrin
Bordeaux, France2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Enrolling by invitation | Phase 2 | 2025-12-10 | NCT06126380 | |
| French eCLIPs™ Efficacy and Safety Investigation | Aneurysm, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial arterial disease, nervous system disorder, vascular disorder | Active, not recruiting | Not applicable | 2025-08-15 | NCT05330897 |